Q2 2025 has demonstrated the pharmaceutical industry’s continued momentum in developing transformative therapies across ...

The second healthcare sector IPCEI – approving up to €403 million of State aid by five Member States, including France, ...

Replimune Group, Inc – a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies – ...

Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the ...

As usual, the one-two punch of ASCO and BIO set us a bit behind, but never fear – your June hires round-up is here at least ...

Saultz and Lochner’s research have long highlighted how relational continuity enhances trust, communication, and shared ...

Nevertheless, there are issues here, too, with long waiting lists, resource constraints, and patient strife when attempting ...

SCOPE is testing administration of intramuscular SCIB1 and intradermal iSCIB1+, which codes for various melanoma antigens ...

The new approval will help Merck make a return on its $3.9 billion investment in acquiring SpringWorks, which has operated as ...

Sanofi has moved to bolster its vaccines business by reaching a deal to buy London, UK-based biotech Vicebio, which was ...

Using microneedle arrays developed at Carnegie Melon, microdosed with a known chemotherapeutic agent delivered directly to ...

The FDA appears to have won its staring contest with Sarepta over shipments of Elevidys, after the company blinked and agreed ...